By proceeding, you agree to our Terms of Use and Privacy Policy.
Hana Cernecka is Head of Inflammation at Bayer
Talks About #healthcare
Preferred Locations #Europe
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.